
A study is presented of the clinico-hemodynamic efficacy of mildronate in 38 patients with ischemic stroke. The drug produces a positive inotropic effect on the myocardium, improves the cerebral hemodynamics in patients with stroke and postischemic hypo- and hyperperfusion of the brain tissue. It is concluded that mildronate may be recommended for the complex treatment of ischemic disorders of the cerebral circulation.
Male, Time Factors, Remission Induction, Hemodynamics, Cardiovascular Agents, Middle Aged, Brain Ischemia, Drug Evaluation, Humans, Female, Aged, Methylhydrazines
Male, Time Factors, Remission Induction, Hemodynamics, Cardiovascular Agents, Middle Aged, Brain Ischemia, Drug Evaluation, Humans, Female, Aged, Methylhydrazines
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
